Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Revenue | 324.71 | 321.23 | 295.67 | 269.16 |
Total Revenue | 324.71 | 321.23 | 295.67 | 269.16 |
Costof Revenue Total | 270.24 | 269.81 | 238.58 | 221.42 |
Gross Profit | 54.46 | 51.42 | 57.10 | 47.75 |
Selling/ General/ Admin Expenses Total | 11.93 | 11.28 | 10.46 | 9.98 |
Depreciation/ Amortization | 3.23 | 1.86 | 0.95 | 1.12 |
Unusual Expense( Income) | -2.35 | - | - | - |
Other Operating Expenses Total | 35.21 | 31.48 | 28.63 | 27.07 |
Total Operating Expense | 318.27 | 314.44 | 278.61 | 259.59 |
Operating Income | 6.44 | 6.79 | 17.06 | 9.57 |
Interest Inc( Exp) Net- Non- Op Total | -5.18 | -5.74 | -1.92 | -1.50 |
Other Net | 1.55 | 1.67 | -5.28 | -5.64 |
Net Income Before Taxes | 2.81 | 2.72 | 9.87 | 2.43 |
Provisionfor Income Taxes | 0.55 | 1.03 | 3.14 | 0.78 |
Net Income After Taxes | 2.26 | 1.69 | 6.73 | 1.65 |
Net Income Before Extra Items | 2.26 | 1.69 | 6.73 | 1.65 |
Net Income | 2.26 | 1.69 | 6.73 | 1.65 |
Income Availableto Com Excl Extra Ord | 2.26 | 1.69 | 6.73 | 1.65 |
Income Availableto Com Incl Extra Ord | 2.26 | 1.69 | 6.73 | 1.65 |
Dilution Adjustment | -0.22 | - | - | - |
Diluted Net Income | 2.04 | 1.69 | 6.73 | 1.65 |
Diluted Weighted Average Shares | 1.68 | 1.75 | 1.36 | 1.87 |
Diluted EPS Excluding Extra Ord Items | 1.21 | 0.97 | 4.93 | 0.88 |
Diluted Normalized EPS | 0.09 | 0.97 | 4.93 | 0.88 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
period Type | - | - | - | - |
DPS- Common Stock Primary Issue | - | 0.25 | - | - |
Cell Point India Dividend Cell Point India Bonus Cell Point India News Cell Point India AGM Cell Point India Rights Cell Point India Splits Cell Point India Board Meetings Cell Point India Key Metrics Cell Point India Shareholdings Cell Point India Balance Sheet Cell Point India Cashflow Cell Point India Q1 Results Cell Point India Q2 Results Cell Point India Q3 Results Cell Point India Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks